微信小陈
微信小章| 产品名称： | Streptococcus pyogenes Rosenbach |
|---|---|
| 商品货号： | TS198688 |
| Deposited As： | Streptococcus hemolyticus Rolly |
| Strain Designations： | Su |
| Application： | Produces antineoplastic agents Produces streptolysin S Emerging infectious disease research |
| Isolation： | Derived from existing strain |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | Lancefields group A |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | S Koshimura |
| U.S. Patent Number： | |
| References： | Okamoto H, Koshimura S. Treating method of Streptococcus hemolyticus and the preparation containing the said microorganism. US Patent 3,477,914 dated Nov 11 1969 Sotomura M, et al. Method for the treatment of cells of Streptococcus pyogenes. US Patent 4,328,218 dated May 4 1982 Okamoto H, et al. Experimental anticancer studies. Part XXXI. On the streptococcal preparation having potent anticancer activity. Jpn. J. Exp. Med. 36: 175-186, 1966. PubMed: 5297294 Okamoto H, et al. Experimental anticancer studies. Part XXX. Factors influencing the streptolysin S-forming ability of streptococci having anticancer activity. Jpn. J. Exp. Med. 36: 161-174, 1966. PubMed: 5297293 derived from ATCC 21059 |